Morningstar Therapeutics

Turn your skin into a gateway for health and beauty.

Morningstar Therapeutics' rolling microneedle particles enable novel pharma and beauty applications, increasing both effect and comfort for our users. Be part of the future of medicine!

Follow Morningstar Therapeutics on LinkedIn

Team

Morningstar Therapeutics was founded by William Ferreira Andrén, studying a MSc in Medical Biotechnology at KTH, Theocharis Nikiforos Iordanidis, a PhD Student at the KTH Division of Micro and Nanosystems, and Niclas Roxhed, Associate Professor at the KTH Division of Micro and Nanosystems.

About the KTH Innovation pre-incubator program

The KTH Innovation pre-incubator program is a 12-month program for promising startup projects from KTH. We welcome new teams into the program twice a year. Around 10% of all ideas that KTH Innovation supports go to the pre-incubator program.

In addition to business development support from KTH Innovation, the teams in the program get access to offices and meeting rooms in KTH Innovation's premises at Teknikringen 1. Every week, they meet over lunch and take part in a tailor-made workshop program.

They also get access to our makerspace and production studio. Together with the program's over 250 alumni projects, they form a supportive community, growing and developing together.

Participants in the program also get an opportunity to get an experienced mentor via KTH Innovation's mentor program, and to pitch for a SEK 250,000 in investment from KTH Holding AB.

Studies

Research

Collaboration

About KTH

Library

Morningstar Therapeutics

Team